Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $88.88 --0%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.60), $0.15 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $47.81 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- Movado Group (MOV) Tops Q2 EPS by 19c, Beats on Revenue; Offers Guidance
- Kohl's (KSS) Tops Q2 EPS by 71c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
